Are OPCH insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies OPCH leadership and institutional positioning as: HEAVY INSIDER & 13F ACCUMULATION.

Stock Ratings / Health Care / OPCH / insiders

LFST (67) HIMS (60) CHE (83) AVAH (65) ⌘ Pro Terminal →

Option Care Health Inc. (OPCH) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$31.69 -0.44% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $31.74

Option Care Health Inc. (OPCH) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (19.3% gross margin, 12% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $4.77B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on OPCH Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is OPCH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Option Care Health Inc. (NASDAQ: OPCH) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $31.69 (-0.44% 1D, market cap $4.77B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 15/20. Across 1015 tracked Health Care issuers, OPCH ranks #39 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does OPCH compare to LFST and HIMS in the Health Care sector?

▼

Within the Health Care sector (Medical/Nursing Services), OPCH carries a Roarable B (74/100 RQD), trailing P/E of 23.0x, gross margin of 19.3%, and ROIC of 11.9%. By comparison, LFST (LifeStance Health Group Inc.) holds a C+ grade (67/100 RQD, P/E N/A, ROIC 1.2%, cap $5.12B) and HIMS (Hims & Hers Health Inc.) posts a C- grade (60/100 RQD, P/E 53.9x, ROIC 8.4%, cap $6.46B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while CHE leads on capital efficiency (23.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for OPCH?

▼

Per OPCH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001014739), Option Care Health Inc. generated $5.65B in revenue (+13.0% YoY), $207.6M in net income, and $217.1M in free cash flow against $3.46B in total assets and $1.15B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $31.74 (+0.16%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 3.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OPCH)Realized 20D OHLCV Swing Band: ±1.8%

Deterministic 5-Pillar Attribution (74/100 Composite)

🔍 WHY OPCH SCORES 74/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (22% of score)

20D Institutional Volume Accumulation (±1.8% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (22% of score)

Altman Z-Score 3.81 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Macro Regime Fit13/20 pts (-7 pt drag)

Macro rate sensitivity & RSI-14 (83.8) create a -7 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B-$31.12+0.5% Next Q

Q2 (-2Q)

Grade B-$31.29+0% Next Q

Q3 (-1Q)

Grade B$31.29+1.3% Next Q

Current

Grade B$31.69+7.3% Hist 90D α

Trajectory: B- (66) → B (74)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the OPCH Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 74/100 (B) score, OPCH faces multiple-compression risk if 23.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 16.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($27.00) or 200D SMA ($26.26) invalidates the momentum regime and cuts Target Base ($33.97) toward Bear Floor ($25.99).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OPCH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “OPCH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 74%NO 26%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

OPCH Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (OPCH)

No recent open-market Form 4 cluster sales or emergency dumps flagged on OPCH. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (OPCH Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

OPCH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +49.91%⚡ TESTING RESISTANCE

2026-11-03O $31.85H $31.85L $31.69C $31.69VOL 4.23M

RES: $32.34SUP: $23.02SMA50: $27.00SMA200: $26.26

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OPCH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 OPCH Butterfly Map → + Track OPCH →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

16.8%/yr Implied 5Y Growth

vs. +13.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on OPCH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for OPCH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for OPCH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OPCH)

Health Care Rank #39 of 1015 ⚔️ LFST vs OPCH Full Matrix →

1. Head-to-Head Health Care Peer Comparison (OPCH vs. LFST, HIMS, CHE, AVAH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Option Care Health Inc. (OPCH) ranks #39 by composite RQD confidence (74/100, grade B) and #166 by equity capitalization ($4.77B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while CHE leads on capital efficiency and profitability with 23.4% ROIC and 32.5% gross margin. CHE currently holds the highest overall quantitative score in the immediate peer group at 83/100 (A-) compared with OPCH at 74/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
OPCH ACTIVE Option Care Health Inc.	B	74/100	23.0x	19.3%	11.9%	-0.44%	$4.77B	Benchmark Subject
LFST LifeStance Health Group Inc.	C+	67/100	—	—	1.2%	-1.04%	$5.12B	/lfst-vs-opch →
HIMS Hims & Hers Health Inc.	C-	60/100	53.9x	73.8%	8.4%	-8.81%	$6.46B	/hims-vs-opch →
CHE Chemed Corp	A-	83/100	—	32.5%	23.4%	+1.40%	$6.96B	/che-vs-opch →
AVAH Aveanna Healthcare Holdings Inc.	C	65/100	—	33.3%	15.7%	-0.30%	$2.87B	/avah-vs-opch →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001014739 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Option Care Health Inc. (OPCH) reported GAAP revenue of $5.65B (+13.0% vs. FY2024 revenue of $5.00B , and +31.3% cumulative change since FY2023) , GAAP net income of $207.6M, operating cash flow of $258.4M, and free cash flow of $217.1M (-24.5% YoY). On the balance sheet, OPCH closed FY2025 with $3.46B in total assets against $1.15B in total debt (Altman Z-Score: 3.81, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$5.65B	$207.6M	$258.4M	$217.1M	$3.46B	$1.15B
FY2024 (FY)	2024-12-31	$5.00B	$211.8M	$323.4M	$287.8M	$3.42B	$1.10B
FY2023 (FY)	2023-12-31	$4.30B	$267.1M	$371.3M	$177.7M	$5.16B	$1.21B

3. OPCH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OPCH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does OPCH compare to LFST and HIMS in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for OPCH?

Where is OPCH trading relative to its 50-day, 200-day, and 52-week technical levels?

OPCH last traded at $31.69 (-0.44% on volume of 2,677,397 shares), positioning the stock +17.37% above its 50-day simple moving average ($27.00) and +20.68% above its 200-day simple moving average ($26.26). Across its 52-week range of $18.01 to $36.80, OPCH sits at the 72.8% percentile with a 14-day RSI of 83.8 (OVERBOUGHT (>70)) and an implied next-earnings move of ±1.8% ($31.12 to $32.26).

Direct Sub-Reports: OPCH RQD Cockpit OPCH 12M Forecast OPCH Earnings & Move OPCH Dividends & DRIP OPCH Insiders & 13F OPCH Whale Options OPCH Profit Sankey OPCH News & Why

ROARABLE RATING BRIEF • RQD 74/100 (B) ✓ SEC XBRL & RQD VERIFIED

OPCH — Option Care Health Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Option Care Health Inc. (OPCH) earns a live Roarable RQD composite score of 74/100, corresponding to a B letter grade (Roarable Buy) at a spot price of $31.69 (-0.44% 1D, market capitalization $4.77B).

Fundamental Cash Engine (14/20): Anchored by return on invested capital (ROIC) of 11.9%, gross margin of 19.3%, operating margin of 6.0%, and free cash flow yield of 4.55%.
Whale 13F & Options Flow (16/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (13/20) + Forensic Balance Sheet (16/20): Incorporates a 1.10x equity beta, Altman Z-Score of 3.81, Piotroski F-Score of 7/9, and Debt/Equity of 0.87x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Option Care Health Inc. Is a NASDAQ-listed issuer in the Health Care sector, operating in the Medical/Nursing Services industry. The company's products, customers, and revenue model are — The company's market capitalization is $4.8B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Option Care Health Inc. (OPCH) reported $5.65B in annual revenue (up from $5.00B in FY2024, +13.0% YoY) and $207.6M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($4.30B revenue, $267.1M net income) through FY2025, OPCH scaled operating cash flow to $258.4M and free cash flow to $217.1M, backed by $3.46B in total assets against $1.15B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (B • RQD 74/100): Big institutional funds and options desks are actively positioning on the bullish side. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 14/20 and Institutional Whale Flow at 16/20, sustained execution supports upside toward the upper end of the $18.01 – $36.80 52-week range.
🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 23.0x trailing P/E and 15.3x EV/EBITDA against 6.0% operating margins and a 1.10x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The Butterfly Supply-Chain Graph lists no upstream or downstream links for OPCH (supply_chain: NONE; butterfly_links: empty). Sector correlations and 2nd-order bottlenecks are — The one identified ripple candidate is the McKesson deal referenced in the Investing.

Key Question #1: Can OPCH sustain or expand its 6.0% operating margin and 11.9% ROIC against Medical/Nursing Services peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $5.65B and free cash flow of $217.1M, how will capital allocation balance growth reinvestment against $1.15B in total debt?
Key Question #3: How sensitive is OPCH's 19.3x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.10x)?

OPCH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Option Care Health Inc. (OPCH) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to OPCH Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 1d ago

Why Option Care Health (OPCH) Stock Is Trading Up Today

Yahoo Finance report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE The Motley Fool • 1d ago

Why Option Care Health Stock Skyrocketed on Tuesday

The Motley Fool report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Barron's • 1d ago

Report of Possible $5 Billion Takeover Bid Sends Option Care Health Stock Surging

Barron's report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST ChartMill • 1d ago

Option Care Health (NASDAQ:OPCH): A Quality Investing Stock With Durable Growth and Strong Cash Generation

ChartMill report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Trefis • 1d ago

A 7-Day Winning Streak Has Option Care Health Stock Up 38%

Trefis report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Investing.com • 1d ago

Citizens downgrades Option Care Health stock rating on McKesson deal

Investing.com report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Option Care Health Agrees to $5.8 Billion Acquisition by CD&R and McKesson at $32.05 Per Share

Yahoo Finance report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Yahoo Finance • 1d ago

Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R

Yahoo Finance report covering Option Care Health Inc. (OPCH) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

OPCH Bull vs. Bear Conversation Board — What's Your Call at $31.69?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OPCH 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $40.42 (+27.0%)

📌 Pinned Debate

Balance-sheet forensics score 16/20 with Altman Z 3.81 and Piotroski F 7/9, alongside a reported takeover-bid report.

Balance-sheet forensics score 16/20 with Altman Z 3.81 and Piotroski F 7/9, alongside a reported takeover-bid report.. When you look under the hood at OPCH, Fundamental Cash Engine is 14/20 with 19.3% gross margins and 11.9% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (16/20) has been quietly accumulating below $36.80. My 12M target is $40.42.

EarningsSniper 🐂 BULL

Both sides have a point here — OPCH's 16/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $24.83 (-22.0%)

Spot @ $31.83

Citizens downgraded OPCH on a McKesson deal while net income fell from $267.1M in FY 2023 to $207.6M in FY 2025.

Careful chasing OPCH at $31.83. Citizens downgraded OPCH on a McKesson deal while net income fell from $267.1M in FY 2023 to $207.6M in FY 2025.. Gross margin is 19.3%, but operating margin is 6.0%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $24.83 on multiple compression.